Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.86 | -0.68 | 25.81 |
| EPS, GAAP | -0.86 | -0.72 | -0.72 |
| Consensus Estimate | -0.62 | -0.51 | 21.57 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | -2.60 | -2.00 | 30.05 |
| EPS, GAAP | -2.64 | -2.03 | 29.95 |
| Consensus Estimate | -2.38 | -1.92 | 23.96 |
| AEGR | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.20 |
| Price/Sales | 0.00 | 18.91 |
| Beta | 1.25 | 0.70 |
| 1/31/2013 | The Clash of the $400,000 Drugs (WSJ.com) |
| 1/30/2013 | Adopting Orphan Drugs (WSJ.com) |
| 12/24/2012 | Aegerion Gets Approval for Cholesterol Drug (WSJ.com) |
| 12/24/2012 | Stocks to Watch: Sony, Groupon, Toyota (WSJ.com) |
